These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 25017909)

  • 21. The NMDA receptor subunit GluN3A protects against 3-nitroproprionic-induced striatal lesions via inhibition of calpain activation.
    Martínez-Turrillas R; Puerta E; Chowdhury D; Marco S; Watanabe M; Aguirre N; Pérez-Otaño I
    Neurobiol Dis; 2012 Dec; 48(3):290-8. PubMed ID: 22801082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycine-dependent activation of NMDA receptors.
    Cummings KA; Popescu GK
    J Gen Physiol; 2015 Jun; 145(6):513-27. PubMed ID: 25964432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pathogenic S688Y mutation in the ligand-binding domain of the GluN1 subunit regulates the properties of NMDA receptors.
    Skrenkova K; Song JM; Kortus S; Kolcheva M; Netolicky J; Hemelikova K; Kaniakova M; Krausova BH; Kucera T; Korabecny J; Suh YH; Horak M
    Sci Rep; 2020 Oct; 10(1):18576. PubMed ID: 33122756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single amino acid residue in the M4 domain of GluN1 subunit regulates the surface delivery of NMDA receptors.
    Kaniakova M; Lichnerova K; Vyklicky L; Horak M
    J Neurochem; 2012 Nov; 123(3):385-95. PubMed ID: 22937865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conformational analysis of NMDA receptor GluN1, GluN2, and GluN3 ligand-binding domains reveals subtype-specific characteristics.
    Yao Y; Belcher J; Berger AJ; Mayer ML; Lau AY
    Structure; 2013 Oct; 21(10):1788-99. PubMed ID: 23972471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GluN3 subunit-containing NMDA receptors: not just one-trick ponies.
    Pachernegg S; Strutz-Seebohm N; Hollmann M
    Trends Neurosci; 2012 Apr; 35(4):240-9. PubMed ID: 22240240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Model structures of the N-methyl-D-aspartate receptor subunit NR1 explain the molecular recognition of agonist and antagonist ligands.
    Moretti L; Pentikäinen OT; Settimo L; Johnson MS
    J Struct Biol; 2004 Mar; 145(3):205-15. PubMed ID: 14960371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synaptic NMDA receptors in basolateral amygdala principal neurons are triheteromeric proteins: physiological role of GluN2B subunits.
    Delaney AJ; Sedlak PL; Autuori E; Power JM; Sah P
    J Neurophysiol; 2013 Mar; 109(5):1391-402. PubMed ID: 23221411
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Skrenkova K; Lee S; Lichnerova K; Kaniakova M; Hansikova H; Zapotocky M; Suh YH; Horak M
    Front Mol Neurosci; 2018; 11():188. PubMed ID: 29915530
    [No Abstract]   [Full Text] [Related]  

  • 30. Molecular dynamics study-based mechanism of nefiracetam-induced NMDA receptor potentiation.
    Omotuyi OI; Ueda H
    Comput Biol Chem; 2015 Apr; 55():14-22. PubMed ID: 25659913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific Roles of NMDA Receptor Subunits in Mental Disorders.
    Yamamoto H; Hagino Y; Kasai S; Ikeda K
    Curr Mol Med; 2015; 15(3):193-205. PubMed ID: 25817860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GluN3A excitatory glycine receptors control adult cortical and amygdalar circuits.
    Bossi S; Dhanasobhon D; Ellis-Davies GCR; Frontera J; de Brito Van Velze M; Lourenço J; Murillo A; Luján R; Casado M; Perez-Otaño I; Bacci A; Popa D; Paoletti P; Rebola N
    Neuron; 2022 Aug; 110(15):2438-2454.e8. PubMed ID: 35700736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conformational rearrangement of the NMDA receptor amino-terminal domain during activation and allosteric modulation.
    Vyklicky V; Stanley C; Habrian C; Isacoff EY
    Nat Commun; 2021 May; 12(1):2694. PubMed ID: 33976221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-synaptic glycine GlyT1 transporter--NMDA receptor interaction: relevance to NMDA autoreceptor activation in the presence of Mg2+ ions.
    Musante V; Summa M; Cunha RA; Raiteri M; Pittaluga A
    J Neurochem; 2011 May; 117(3):516-27. PubMed ID: 21348870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of the intracellular GluN2 C-terminal domain on NMDA receptor function.
    Punnakkal P; Jendritza P; Köhr G
    Neuropharmacology; 2012 Apr; 62(5-6):1985-92. PubMed ID: 22245680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of N-methyl-D-aspartate receptors by glycine: role of an aspartate residue in the M3-M4 loop of the NR1 subunit.
    Williams K; Chao J; Kashiwagi K; Masuko T; Igarashi K
    Mol Pharmacol; 1996 Oct; 50(4):701-8. PubMed ID: 8863813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells.
    Priestley T; Laughton P; Myers J; Le Bourdellés B; Kerby J; Whiting PJ
    Mol Pharmacol; 1995 Nov; 48(5):841-8. PubMed ID: 7476914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ionotropic glutamate-like receptor delta2 binds D-serine and glycine.
    Naur P; Hansen KB; Kristensen AS; Dravid SM; Pickering DS; Olsen L; Vestergaard B; Egebjerg J; Gajhede M; Traynelis SF; Kastrup JS
    Proc Natl Acad Sci U S A; 2007 Aug; 104(35):14116-21. PubMed ID: 17715062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits.
    Chatterton JE; Awobuluyi M; Premkumar LS; Takahashi H; Talantova M; Shin Y; Cui J; Tu S; Sevarino KA; Nakanishi N; Tong G; Lipton SA; Zhang D
    Nature; 2002 Feb; 415(6873):793-8. PubMed ID: 11823786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GluN3A NMDA receptor subunits: more enigmatic than ever?
    Crawley O; Conde-Dusman MJ; Pérez-Otaño I
    J Physiol; 2022 Jan; 600(2):261-276. PubMed ID: 33942912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.